Glipizide is an oral antidiabetic medication primarily prescribed for the treatment of type 2 diabetes mellitus. As a member of the sulfonylurea class, it acts by stimulating the pancreas to produce more insulin, thus lowering blood sugar levels. First approved by the FDA in the 1980s, Glipizide has remained a staple in diabetes therapy due to its rapid action, manageable side effect profile, and excellent track record of patient compliance. Manufactured under various brand names such as Glucotrol, Glibenese, and others, Glipizide comes in both immediate and extended-release forms, offering flexibility depending on patient needs. Over the decades, this tablet has earned trust through its reliability and consistency in managing blood glucose levels.